• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刺激 PBMC 产生的 IFN-γ 和 TNF-α 与多发性硬化症的复发风险改变有关:来自前瞻性队列研究的结果。

Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study.

机构信息

Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia.

School of Medicine, University of Tasmania, Hobart, Tasmania, Australia School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia.

出版信息

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):200-7. doi: 10.1136/jnnp-2013-307336. Epub 2014 May 1.

DOI:10.1136/jnnp-2013-307336
PMID:24790215
Abstract

BACKGROUND

Altered reactivity of peripheral blood mononuclear cells (PBMC) and their production of cytokines may affect multiple sclerosis (MS) clinical course. We assessed the relationship of stimulated PBMC-produced IFN-γ, TNF-α, IL-4 and IL-10 in modulating relapse risk using a prospective cohort with established relapsing-remitting MS.

METHODS

Cytokine production from PBMCs taken in summer and winter was measured by ELISA. Predictors of cytokines assessed by multilevel mixed-effects linear regression. Predictors of relapse assessed by survival analysis.

RESULTS

Increasing IFN-γ was associated with increasing relapse risk, while increasing TNF-α reduced relapse risk after adjusting for IFN-γ. IL-10 and IL4 were not consistently associated with relapse risk. IFN-γ's effects on relapse were greatly attenuated by immunomodulatory therapies, by summer season and by higher serum vitamin D, whereas TNF-α's inverse association with relapse was only present in these circumstances. The TNF-α inverse association with relapse was only present among persons carrying the wild-type of the functional SNP rs1800693 in TNFRSF1A that has been previously associated with MS risk.

CONCLUSIONS

We found strong effects of IFN-γ and TNF-α on relapse risk, these differing by immunomodulatory therapy, season, and serum vitamin D, as well as by genotype. These results indicate altered reactivity of immune cells modulate MS disease.

摘要

背景

外周血单个核细胞 (PBMC) 的反应性改变及其细胞因子的产生可能会影响多发性硬化症 (MS) 的临床病程。我们评估了使用已建立的复发缓解型 MS 的前瞻性队列,研究刺激 PBMC 产生的 IFN-γ、TNF-α、IL-4 和 IL-10 对调节复发风险的关系。

方法

通过 ELISA 测量 PBMC 在夏季和冬季产生的细胞因子。使用多级混合效应线性回归来评估细胞因子的预测因子。通过生存分析评估复发的预测因子。

结果

调整 IFN-γ 后,IFN-γ 增加与复发风险增加相关,而 TNF-α 增加则降低复发风险。IL-10 和 IL4 与复发风险没有一致的相关性。免疫调节治疗、夏季和较高的血清维生素 D 大大减弱了 IFN-γ 对复发的影响,而 TNF-α 与复发的反比关系仅在这些情况下存在。TNF-α 与复发的反比关系仅存在于 TNFRSF1A 中的功能性 SNP rs1800693 携带野生型的个体中,该 SNP 先前与 MS 风险相关。

结论

我们发现 IFN-γ 和 TNF-α 对复发风险有很强的影响,这些影响因免疫调节治疗、季节和血清维生素 D 以及基因型而异。这些结果表明,免疫细胞的反应性改变调节了 MS 疾病。

相似文献

1
Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study.刺激 PBMC 产生的 IFN-γ 和 TNF-α 与多发性硬化症的复发风险改变有关:来自前瞻性队列研究的结果。
J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):200-7. doi: 10.1136/jnnp-2013-307336. Epub 2014 May 1.
2
Genetic variation in PBMC-produced IFN-γ and TNF-α associations with relapse in multiple sclerosis.外周血单核细胞产生的干扰素-γ和肿瘤坏死因子-α的基因变异与多发性硬化症复发的关联
J Neurol Sci. 2015 Feb 15;349(1-2):40-4. doi: 10.1016/j.jns.2014.12.022. Epub 2014 Dec 19.
3
Clinical and laboratory study of pro-inflammatory and antiinflammatory cytokines in women with multiple sclerosis.多发性硬化症女性患者促炎和抗炎细胞因子的临床与实验室研究
Folia Med (Plovdiv). 2011 Apr-Jun;53(2):29-35. doi: 10.2478/v10153-010-0034-x.
4
Modulating effects of WT1 on interferon-β-vitamin D association in MS.WT1对多发性硬化症中干扰素-β - 维生素D关联的调节作用。
Acta Neurol Scand. 2015 Apr;131(4):231-9. doi: 10.1111/ane.12315. Epub 2014 Oct 14.
5
[The effect of interleukin-7 and interleukin-15 on the production of Th1 and Th2 cytokines by peripheral blood mononuclear cells from patients with tuberculosis].[白细胞介素-7和白细胞介素-15对肺结核患者外周血单个核细胞产生Th1和Th2细胞因子的影响]
Zhonghua Jie He He Hu Xi Za Zhi. 2006 Jun;29(6):403-6.
6
Association between multiple sclerosis risk-associated SNPs and relapse and disability--a prospective cohort study.多发性硬化症风险相关 SNP 与复发和残疾的关联——一项前瞻性队列研究。
Mult Scler. 2014 Mar;20(3):313-21. doi: 10.1177/1352458513496882. Epub 2013 Jul 25.
7
Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients.多发性硬化症患者外周血中体外促炎细胞因子产生的性别差异。
J Neurol Sci. 2003 May 15;209(1-2):93-9. doi: 10.1016/s0022-510x(03)00004-2.
8
A spring to summer shift of pro-inflammatory cytokine production in multiple sclerosis patients.多发性硬化症患者促炎细胞因子产生从春季到夏季的转变。
J Neurol Sci. 2016 Jan 15;360:37-40. doi: 10.1016/j.jns.2015.11.022. Epub 2015 Nov 12.
9
Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis.PKC 家族基因对血清维生素 D 与多发性硬化症复发关系的新调节作用。
J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):399-404. doi: 10.1136/jnnp-2013-305245. Epub 2013 Jul 18.
10
Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.在接受β-1b干扰素治疗的日本多发性硬化症患者中,细胞因子随时间向Th2方向偏移。
J Neurol Sci. 2004 Jul 15;222(1-2):65-73. doi: 10.1016/j.jns.2004.04.012.

引用本文的文献

1
Decoding the Potential Impact of Plasma hsa-miR-24-3p and hsa-miR-181 d-3p Expression, Plasma IFN-γ Levels, and IFNG rs2069727 T/C Genetic Variant on Multiple Sclerosis Risk and Glatiramer Acetate Treatment.解码血浆hsa-miR-24-3p和hsa-miR-181d-3p表达、血浆IFN-γ水平以及IFNG rs2069727 T/C基因变异对多发性硬化症风险和醋酸格拉替雷治疗的潜在影响。
Mol Neurobiol. 2025 Jun 2. doi: 10.1007/s12035-025-05027-9.
2
Ursolic acid derivatives improved clinical signs of experimental autoimmune encephalomyelitis by modulating central nervous system inflammation.熊果酸衍生物通过调节中枢神经系统炎症改善了实验性自身免疫性脑脊髓炎的临床症状。
Metab Brain Dis. 2025 Apr 1;40(4):166. doi: 10.1007/s11011-025-01591-0.
3
Relationship Between T-helper 1 Inflammatory Biomarkers and Hematological Index Responses in Patients With Multiple Sclerosis.
多发性硬化症患者中辅助性T细胞1炎症生物标志物与血液学指标反应之间的关系
Cureus. 2024 Dec 7;16(12):e75278. doi: 10.7759/cureus.75278. eCollection 2024 Dec.
4
Ursolic acid derivative UAOS-Na treats experimental autoimmune encephalomyelitis by immunoregulation and protecting myelin.熊果酸衍生物UAOS-Na通过免疫调节和保护髓鞘来治疗实验性自身免疫性脑脊髓炎。
Front Neurol. 2023 Nov 30;14:1269862. doi: 10.3389/fneur.2023.1269862. eCollection 2023.
5
Predictors of progression from a first demyelinating event to clinically definite multiple sclerosis.首次脱髓鞘事件进展为临床确诊多发性硬化症的预测因素。
Brain Commun. 2022 Jul 9;4(4):fcac181. doi: 10.1093/braincomms/fcac181. eCollection 2022.
6
Factors associated with relapses in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis.复发缓解型多发性硬化症复发的相关因素:一项系统综述和荟萃分析。
Medicine (Baltimore). 2020 Jul 2;99(27):e20885. doi: 10.1097/MD.0000000000020885.
7
Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions.多发性硬化症中的多巴胺能疗法:聚焦于辅助性T细胞17(Th17)细胞功能
J Neuroimmune Pharmacol. 2020 Mar;15(1):37-47. doi: 10.1007/s11481-019-09852-3. Epub 2019 Apr 23.
8
Expression analysis of long non-coding RNAs and their target genes in multiple sclerosis patients.多发性硬化症患者中长非编码 RNA 及其靶基因的表达分析。
Neurol Sci. 2019 Apr;40(4):801-811. doi: 10.1007/s10072-019-3720-3. Epub 2019 Jan 24.
9
Assessment and Treatment Strategies for a Multiple Sclerosis Relapse.多发性硬化症复发的评估与治疗策略
J Immunol Clin Res. 2018;5(1). Epub 2016 Dec 7.
10
Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity.基于铂的纳米载体,与免疫调节佐剂联合,用于抑制肿瘤生长和促进免疫。
Theranostics. 2018 Apr 18;8(11):2974-2987. doi: 10.7150/thno.24110. eCollection 2018.